期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HIV蛋白酶抑制剂的药物相互作用研究进展 被引量：4

下载PDF
导出
摘要 治疗HIV感染时,由于用药种类及数量众多,常不可避免的发生药物相互作用。HIV蛋白酶抑制剂(PIs)的药动学特点,使其易与其他药物发生复杂的药物相互作用。临床医师应充分了解并正确处理PIs的药物相互作用。本文综述近年来有关PIs相互作用的研究进展,重点介绍常见PIs药物相互作用及其机制,讨论预防及减少不良相互作用的方法。
作者 邓万俊
机构地区 南华大学附属南华医院
出处 《国外医药（抗生素分册）》 CAS 2006年第1期9-15,共7页 World Notes on Antibiotics
关键词 人类免疫缺损病毒 HIV 蛋白酶抑制剂 药物相互作用 药动学 药效学
分类号 R978.7 [医药卫生—药品]
  • 相关文献

参考文献33

  • 1Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections [ J ]. N Engl J Med,2001,344(13) :984.
  • 2Winston A, Boffito M. The management of HIV - 1 protease inhibitor pharmacokinetic interactions [ J ]. J Antimicrob Chemother,2005,56(1) : 1.
  • 3Gallant JE. Protease inhibitor boosting in the treatment experienced patients [ J ]. AIDS Rev,2004,6 (4) :226.
  • 4Zeldin RK, Petruschke RA. Pharmacological and therapeutic propertics of ritonavir - boosted protease inhibitor therapy in HIV - infected patients [ J ]. J Antimicrob Chemother,2004 ,53(1) :4.
  • 5Plosker GL,Scott LJ. Saquinavir: a review of its use in boosted regiments for treating HIV infection [ J ]. Drugs,2003,63 (12) :1299.
  • 6Walmsley S, Bernstein B, King M, et al. Lopinavir - ritonavir versus nalfinavir for the initial treatment of HIV infection [J]. N Engl J Meal,2002,346(26) :2039.
  • 7Qazi NA, Morlese JF, Pozniak AL. Lopinavir/ritonavir ( ABT - 378/r ) [ J ]. Expert Opin Pharmacother, 2002,3 ( 3 ) : 315.
  • 8Becker SL. The role of pharmacological enhancement in protease inhibitor - based highly active antiretroviral therapy [J]. Expert Opin lnvestig Drugs,2003,12(3) :401.
  • 9Malta B, Michael K, Guido K, et al. Atazanavir enhances saquinavir hard - gel concentrations in a ritonavir-boosted once - daily regimen [ J ]. AIDS, 2004,18 ( 9 ) : 1291.
  • 10Winston A, Bloch M, Carr A, et al. Atazanavir trough plasma concentration monitoring in a cohort of HIV - 1 positive individuals receiving highly active retroviral therapy [ J ]. J Antimicrob Chemother,2005,56 ( 2 ) :380.

同被引文献91

  • 1Gottesman MM, Pastan I. Biochemistry of multi- drug resistance mediated by the multidrug trans- porter[J]. Annu Rev Biochem, 1993, 62: 385- 427.
  • 2Solon EG, Balani SK, Luo G, et al. Interaction of ritonavir on tissue distribution of a [(14) c] L-vali- namide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole- body autoradiography [ J ]. Drug Metab Dispos, 2002,30(11): 1164--1169.
  • 3Drewe J, Gutmann H, Fricker G, et al. HIV prote- ase inhibitor ritonavir: a more potent inhibitor of P- glycoprotein than the cyclosporine analog SDZ PSC 833[J]. Biochem Pharmaeol,1999, 57(10) : 1147-- 1152.
  • 4Shaik N, Pan G, Elmquist WF, et al. Interactions of pluronic block copolymers on P-gp efflux activi- ty: experience with HIV-1 protease inhibitors[J]. J Pharm Sci,2008,97(12) : 5421--5433.
  • 5Kaddoumi A, Choi SU, Kinman L, et al. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid[J]. Drug Metab Dispos,2007, 35(9) :1459--1462.
  • 6Storch CH, Theile D, Lindenmaier H,et al. Com- parison of the inhibitory activity of anti-HIV drugs on P-glycoprotein[J]. Biochem Pharmacol, 2007,73 (10) : 1573--1581.
  • 7Haas DW, Wu HL, Bosch RJ,et al. MDR1 gene polymorphisms and phase 1 viral decay during HIV- 1 infection., an adult AIDS Clinical Trials Group study[J]. J Acquir Immune Defic Syndr, 2003,34 (3) : 295--298.
  • 8Lucia MB, Rutella S, Leone G, et al. HIV-prote- ase inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART[J]. J Acquir Immune Defic Syndr, 2001,27 (4) : 321 -- 230.
  • 9Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions[J]. Life Sci, 2006,78 (18) : 2131--2145.
  • 10Berginc K, Trdan T, Trontelj J,et al. HIV prote-ase inhibitors: garlic supplements and first-pass in- testinal metabolism impact on the therapeutic effica- cy[J]. Biopharm Drug Dispos, 2010 , 31 (8/9) : 495 --505.

引证文献4

二级引证文献12

国外医药（抗生素分册）
2006年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部